Article (Scientific journals)
Phenotypes and genotypes in non-consanguineous and consanguineous primary microcephaly: High incidence of epilepsy
Duerinckx, S.; Désir, J.; Perazzolo, C. et al.
2021In Molecular Genetics and Genomic Medicine, 9 (9)
Peer Reviewed verified by ORBi
 

Files


Full Text
Phenotypes and genotypes in non-consanguineous and consanguineous primary microcephaly - high incidence of epilepsy.pdf
Author postprint (1.3 MB) Creative Commons License - Attribution, Non-Commercial, No Derivative
Download

All documents in ORBi are protected by a user license.

Send to



Details



Keywords :
brain developmental disorders; consanguinity; epilepsy; Mendeliome; primary microcephaly; rare disease; ASPM protein, human; cell cycle protein; nerve protein; WDR62 protein, human; child; complication; female; gene frequency; genetic heterogeneity; genetics; genotype; human; incidence; male; microcephaly; pathology; phenotype; Cell Cycle Proteins; Child; Consanguinity; Epilepsy; Female; Gene Frequency; Genetic Heterogeneity; Genotype; Humans; Incidence; Male; Microcephaly; Nerve Tissue Proteins; Phenotype
Abstract :
[en] Background: Primary microcephaly (PM) is defined as a significant reduction in occipitofrontal circumference (OFC) of prenatal onset. Clinical and genetic heterogeneity of PM represents a diagnostic challenge. Methods: We performed detailed phenotypic and genomic analyses in a large cohort (n = 169) of patients referred for PM and could establish a molecular diagnosis in 38 patients. Results: Pathogenic variants in ASPM and WDR62 were the most frequent causes in non-consanguineous patients in our cohort. In consanguineous patients, microarray and targeted gene panel analyses reached a diagnostic yield of 67%, which contrasts with a much lower rate in non-consanguineous patients (9%). Our series includes 11 novel pathogenic variants and we identify novel candidate genes including IGF2BP3 and DNAH2. We confirm the progression of microcephaly over time in affected children. Epilepsy was an important associated feature in our PM cohort, affecting 34% of patients with a molecular confirmation of the PM diagnosis, with various degrees of severity and seizure types. Conclusion: Our findings will help to prioritize genomic investigations, accelerate molecular diagnoses, and improve the management of PM patients. © 2021 The Authors. Molecular Genetics & Genomic Medicine published by Wiley Periodicals LLC
Disciplines :
Genetics & genetic processes
Author, co-author :
Duerinckx, S.;  Institut de Recherche Interdisciplinaire en Biologie Humaine et moléculaire, Université Libre de Bruxelles, Brussels, Belgium
Désir, J.;  Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Gosselies, Belgium
Perazzolo, C.;  Institut de Recherche Interdisciplinaire en Biologie Humaine et moléculaire, Université Libre de Bruxelles, Brussels, Belgium
Badoer, C.;  Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium
Jacquemin, V.;  Institut de Recherche Interdisciplinaire en Biologie Humaine et moléculaire, Université Libre de Bruxelles, Brussels, Belgium
Soblet, J.;  Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles, Brussels, Belgium
Maystadt, I.;  Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Gosselies, Belgium
Tunca, Y.;  Department of Medical Genetics, Gülhane Faculty of Medicine & Gülhane Training and Research Hospital, University of Health Sciences Turkey, Ankara, Turkey
Blaumeiser, B.;  University and University Hospital of Antwerp, Antwerp, Belgium
Ceulemans, B.;  University and University Hospital of Antwerp, Antwerp, Belgium
COURTENS, Winnie ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique
Debray, François-Guillaume ;  Centre Hospitalier Universitaire de Liège - CHU > > Service de génétique
Destree, A.;  Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Gosselies, Belgium
Devriendt, K.;  Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium
Jansen, A.;  Universitair Ziekenhuis Brussel (UZ Brussel), Centrum Medische Genetica, Universiteit Brussel (VUB), Brussels, Belgium
Keymolen, K.;  Universitair Ziekenhuis Brussel (UZ Brussel), Centrum Medische Genetica, Universiteit Brussel (VUB), Brussels, Belgium
Lederer, D.;  Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Gosselies, Belgium
Loeys, B.;  University and University Hospital of Antwerp, Antwerp, Belgium
Meuwissen, M.;  University and University Hospital of Antwerp, Antwerp, Belgium
Moortgat, S.;  Centre de Génétique Humaine, Institut de Pathologie et de Génétique, Gosselies, Belgium
Mortier, G.;  University and University Hospital of Antwerp, Antwerp, Belgium
Nassogne, M.-C.;  Cliniques Universitaires Saint-Luc, Université Catholique de Louvain, Brussels, Belgium
Sekhara, T.;  Centre Hospitalier CHIREC, Brussels, Belgium
Van Coster, R.;  Universitair Ziekenhuis Gent, Ghent, Belgium
Van Den Ende, J.;  University and University Hospital of Antwerp, Antwerp, Belgium
Van der Aa, N.;  University and University Hospital of Antwerp, Antwerp, Belgium
Van Esch, H.;  Center for Human Genetics, University Hospitals Leuven, Leuven, Belgium
Vanakker, O.;  Universitair Ziekenhuis Gent, Ghent, Belgium
Verhelst, H.;  Universitair Ziekenhuis Gent, Ghent, Belgium
Vilain, C.;  Department of Genetics, Hôpital Erasme, ULB Center of Human Genetics, Université Libre de Bruxelles, Brussels, Belgium, Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles, Brussels, Belgium
Weckhuysen, S.;  University and University Hospital of Antwerp, Antwerp, Belgium
Passemard, S.;  Department of Genetics, APHP, Robert Debré University Hospital, Paris, France
Verloes, A.;  Department of Genetics, APHP, Robert Debré University Hospital, Paris, France
Aeby, A.;  Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles, Brussels, Belgium
Deconinck, N.;  Hôpital Universitaire des Enfants Reine Fabiola (HUDERF), Université Libre de Bruxelles, Brussels, Belgium
Van Bogaert, P.;  Department of Pediatrics, Centre Hospitalier Universitaire d’Angers, France
Pirson, I.;  Institut de Recherche Interdisciplinaire en Biologie Humaine et moléculaire, Université Libre de Bruxelles, Brussels, Belgium
Abramowicz, M.;  Institut de Recherche Interdisciplinaire en Biologie Humaine et moléculaire, Université Libre de Bruxelles, Brussels, Belgium, Department of Genetic Medicine and Development, University of Geneva, Genève, Switzerland
More authors (28 more) Less
Language :
English
Title :
Phenotypes and genotypes in non-consanguineous and consanguineous primary microcephaly: High incidence of epilepsy
Publication date :
2021
Journal title :
Molecular Genetics and Genomic Medicine
eISSN :
2324-9269
Publisher :
John Wiley and Sons Inc
Volume :
9
Issue :
9
Peer reviewed :
Peer Reviewed verified by ORBi
Funding text :
This work was supported by ERA‐net E‐Rare Euromicro and the Action de Recherche Concertée (ARC) of the Belgian Fédération Wallonie Bruxelles to M.A., the Fonds de la Recherche Scientifique FRS‐FNRS Belgium and the Fonds de soutien Marguerite‐Marie Delacroix to S.D., the Fonds Erasme to M.A. and to S.D., and the Université Libre de Bruxelles to I.P.
Available on ORBi :
since 26 January 2024

Statistics


Number of views
1 (0 by ULiège)
Number of downloads
1 (0 by ULiège)

Scopus citations®
 
5
Scopus citations®
without self-citations
3
OpenCitations
 
1

Bibliography


Similar publications



Contact ORBi